Genentech, Inc. is a pioneering biotechnology company focused on discovering, developing, manufacturing, and commercializing medicines to treat serious and life‑threatening medical conditions, particularly in oncology, immunology, and neuroscience. Founded in 1976 and now a member of the Roche Group, Genentech is widely regarded as one of the founders of the modern biotech industry and operates as an independent research‑driven organization within Roche.
Genentech primarily uses AI and machine learning as enabling technologies across drug discovery, clinical development, and manufacturing, rather than as standalone commercial products. The company collaborates with technology partners and internal data science teams to apply advanced analytics, computational biology, and ML models to target identification, biomarker discovery, trial design, and personalized medicine.